Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Volkin

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
Journal of Pharmaceutical Sciences|February 13, 2016
Biosimilarity Assessments of Model IgG1-Fc Glycoforms Using a Machine Learning ApproachJae Hyun Kim, Sangeeta B Joshi, Thomas J Tolbert, et al.
Vaccines|June 25, 2026
Three Competitive ELISAs to Quantify the D-Antigen Content of Aluminum-Salt Adjuvanted Recombinant Polio VLPs (Types 1, 2, 3) to Enable Preformulation Characterization StudiesYanli Liu, John M Hickey, Geetha Satya Sainaga Jyothi Vaskuri, et al.
Journal of Pharmaceutical Sciences|June 16, 2019
Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1Yue Hu, Jayant Arora, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|January 26, 2025
Two recombinant cytomegalovirus antigens formulated with the SPA14 adjuvant system: Impact of temperature, pH and excipients on the stability of each antigen and adjuvant componentJohn M Hickey, Ozan S Kumru, François Dalençon, et al.
Journal of Pharmaceutical Sciences|July 3, 2016
A Micro-Polyethylene Glycol Precipitation Assay as a Relative Solubility Screening Tool for Monoclonal Antibody Design and Formulation DevelopmentVishal M Toprani, Sangeeta B Joshi, Lisa A Kueltzo, et al.
Journal of Pharmaceutical Sciences|July 3, 2017
A Formulation Development Approach to Identify and Select Stable Ultra-High-Concentration Monoclonal Antibody Formulations With Reduced ViscositiesNeal Whitaker, Jian Xiong, Samantha E Pace, et al.
Journal of the American Society for Mass Spectrometry|September 21, 2012
Minimizing carry-over in an online pepsin digestion system used for the H/D exchange mass spectrometric analysis of an IgG1 monoclonal antibodyRanajoy Majumdar, Prakash Manikwar, John M Hickey, et al.
Protein Science : a Publication of the Protein Society|July 30, 2013
Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodiesSantosh V Thakkar, Neha Sahni, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|February 18, 2016
Improved Comparative Signature Diagrams to Evaluate Similarity of Storage Stability Profiles of Different IgG1 mAbsJae Hyun Kim, Sangeeta B Joshi, Reza Esfandiary, et al.
Human Vaccines & Immunotherapeutics|May 7, 2021
Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch<sup>TM</sup> Microneedle Delivery SystemYing Wan, Vineet Gupta, Christopher Bird, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
Journal of Pharmaceutical Sciences|February 13, 2016
Biosimilarity Assessments of Model IgG1-Fc Glycoforms Using a Machine Learning ApproachJae Hyun Kim, Sangeeta B Joshi, Thomas J Tolbert, et al.
Vaccines|June 25, 2026
Three Competitive ELISAs to Quantify the D-Antigen Content of Aluminum-Salt Adjuvanted Recombinant Polio VLPs (Types 1, 2, 3) to Enable Preformulation Characterization StudiesYanli Liu, John M Hickey, Geetha Satya Sainaga Jyothi Vaskuri, et al.
Journal of Pharmaceutical Sciences|June 16, 2019
Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1Yue Hu, Jayant Arora, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|January 26, 2025
Two recombinant cytomegalovirus antigens formulated with the SPA14 adjuvant system: Impact of temperature, pH and excipients on the stability of each antigen and adjuvant componentJohn M Hickey, Ozan S Kumru, François Dalençon, et al.
Journal of Pharmaceutical Sciences|July 3, 2016
A Micro-Polyethylene Glycol Precipitation Assay as a Relative Solubility Screening Tool for Monoclonal Antibody Design and Formulation DevelopmentVishal M Toprani, Sangeeta B Joshi, Lisa A Kueltzo, et al.
Journal of Pharmaceutical Sciences|July 3, 2017
A Formulation Development Approach to Identify and Select Stable Ultra-High-Concentration Monoclonal Antibody Formulations With Reduced ViscositiesNeal Whitaker, Jian Xiong, Samantha E Pace, et al.
Journal of the American Society for Mass Spectrometry|September 21, 2012
Minimizing carry-over in an online pepsin digestion system used for the H/D exchange mass spectrometric analysis of an IgG1 monoclonal antibodyRanajoy Majumdar, Prakash Manikwar, John M Hickey, et al.
Protein Science : a Publication of the Protein Society|July 30, 2013
Understanding the relevance of local conformational stability and dynamics to the aggregation propensity of an IgG1 and IgG2 monoclonal antibodiesSantosh V Thakkar, Neha Sahni, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|February 18, 2016
Improved Comparative Signature Diagrams to Evaluate Similarity of Storage Stability Profiles of Different IgG1 mAbsJae Hyun Kim, Sangeeta B Joshi, Reza Esfandiary, et al.
Human Vaccines & Immunotherapeutics|May 7, 2021
Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch<sup>TM</sup> Microneedle Delivery SystemYing Wan, Vineet Gupta, Christopher Bird, et al.
Pageof 18